Manning & Napier Group
PFE icon

Manning & Napier Group’s Pfizer PFE Stock Holding History

Manning & Napier Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$22.8M Sell
820,365
-53,889
-6% -$1.5M 0.26% 81
2023
Q4 		$25.2M Sell
874,254
-152,276
-15% -$4.6M 0.3% 77
2023
Q3 		$34M Sell
1,026,530
-30,419
-3% -$1.08M 0.42% 64
2023
Q2 		$38.8M Buy
1,056,949
+287,261
+37% +$11.2M 0.44% 63
2023
Q1 		$31.4M Sell
769,688
-1,811
-0.2% -$78.2K 0.37% 71
2022
Q4 		$39.5M Sell
771,499
-5,768
-0.7% -$277K 0.49% 56
2022
Q3 		$34M Sell
777,267
-11,859
-2% -$576K 0.44% 58
2022
Q2 		$41.4M Buy
+789,126
New +$40.2M 0.48% 57
2021
Q2 		– Sell
-1,455,218
Closed -$52.7M – 302
2021
Q1 		$52.7M Buy
1,455,218
+30,588
+2% +$1.09M 0.45% 68
2020
Q4 		$52.4M Sell
1,424,630
-158,200
-10% -$5.8M 0.49% 62
2020
Q3 		$55.1M Buy
1,582,830
+10,242
+0.7% +$359K 0.56% 56
2020
Q2 		$48.8M Buy
1,572,588
+26,407
+2% +$897K 0.52% 60
2020
Q1 		$47.9M Buy
1,546,181
+39,007
+3% +$1.33M 0.56% 56
2019
Q4 		$56M Buy
1,507,174
+108,755
+8% +$3.87M 0.6% 49
2019
Q3 		$47.7M Buy
1,398,419
+49,287
+4% +$1.79M 0.53% 52
2019
Q2 		$55.4M Buy
1,349,132
+77,709
+6% +$3.09M 0.6% 44
2019
Q1 		$51.2M Buy
1,271,423
+266,222
+26% +$10.7M 0.56% 47
2018
Q4 		$41.6M Buy
1,005,201
+64,595
+7% +$2.68M 0.51% 51
2018
Q3 		$39.3M Buy
940,606
+55,060
+6% +$2.12M 0.39% 63
2018
Q2 		$30.5M Sell
885,546
-142,713
-14% -$4.88M 0.3% 70
2018
Q1 		$34.6M Buy
1,028,259
+210,360
+26% +$7.23M 0.34% 66
2017
Q4 		$28.1M Buy
+817,899
New +$27.9M 0.25% 79

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Manning & Napier Group's PFE Position: Q1 2024 in Review

Manning & Napier Group reduced its Pfizer (PFE) stake by 6.2% in Q1 2024, selling an estimated $1.5M and leaving 820,365 shares worth $22.8M. The position accounts for 0.26% of the portfolio, ranked #81.

Manning & Napier Group first reported a position in PFE in Q4 2017 and has held it in 22 quarters since. The position peaked at $56M in Q4 2019. 2,883 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Manning & Napier Group held 820,365 shares of Pfizer worth $22.8M as of Q1 2024.
  • Manning & Napier Group sold 53,889 Pfizer shares in Q1 2024, an estimated $1.5M.
  • Pfizer made up 0.26% of Manning & Napier Group's portfolio in Q1 2024, its #81 holding.
  • Manning & Napier Group first reported a position in Pfizer in Q4 2017 and has held it in 22 quarters since.
  • Manning & Napier Group's Pfizer position peaked at $56M in Q4 2019.
  • 2,883 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.